Trial Profile

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 21 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Rocapuldencel T (Primary) ; Carboplatin; Cisplatin; Paclitaxel; Pemetrexed
Indications Non-small cell lung cancer
Focus Adverse reactions; Pharmacodynamics

Most Recent Events

20 Jul 2020 Planned initiation date changed from 1 Feb 2016 to 1 Mar 2016.
20 Jul 2020 Status changed from recruiting to withdrawn prior to enrolment.
07 Mar 2018 The recruitment status of this study is unknown because trial information has not been verified since 25 March 2016.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com